• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用丙脒腙和聚六亚甲基双胍(PHMB)治疗的棘阿米巴角膜炎

[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].

作者信息

Donoso Rodrigo, Mura Juan José, López Mauricio

机构信息

Servicio de Oftalmología, Hospital del Salvador, Santiago-Chile.

出版信息

Rev Med Chil. 2002 Apr;130(4):396-401.

PMID:12090104
Abstract

BACKGROUND

The diagnosis of acanthamoeba keratitis has increased since 1985 due to the massive use of contact lenses and a better knowledge of the disease by ophthalmologists. The use of biassociated therapy has resulted in a better prognosis and lower complication rate.

AIM

To report patients with acanthamoeba keratitis treated with the association of propamidine (Brolene) and polyhexamethylbiguanide (PHMB) 0.02%.

PATIENTS AND METHODS

Retrospective analysis of 27 patients (31 eyes) with acanthamoeba keratitis (bilateral in four cases), diagnosed by culture, biopsy or characteristic clinical features.

RESULTS

Ninety six percent of patients used rigid contact lenses. Acanthamoeba cultures were positive in 71% of cases. The delay in the diagnosis was between 1 and 5 months. Early treatment was possible in 29% of patients. Infection was irradicated in all cases with the biassociated therapy. A tectonic keratoplasty to treat a trophic perforation was done in eight eyes. No patient required therapeutic keratoplasty to resolve the infection. Visual acuity at the end of follow up was better than 20/40 in nine patients and in eight it was in the range of count fingers or less.

CONCLUSIONS

In patients with the clinical picture of acanthamoeba keratitis, early or late antiamoebic treatment is warranted even in the absence of positive cultures. The visual results of the treatment are highly dependent on the precocity of treatment. Prevention is imperative and is based on a strict contact lens hygiene.

摘要

背景

自1985年以来,由于隐形眼镜的大量使用以及眼科医生对该疾病的进一步了解,棘阿米巴角膜炎的诊断病例有所增加。联合治疗的应用带来了更好的预后和更低的并发症发生率。

目的

报告使用丙脒腙(Brolene)和0.02%聚己基双胍(PHMB)联合治疗的棘阿米巴角膜炎患者。

患者与方法

对27例(31只眼)棘阿米巴角膜炎患者(4例为双眼患病)进行回顾性分析,通过培养、活检或特征性临床特征进行诊断。

结果

96%的患者使用硬性隐形眼镜。71%的病例棘阿米巴培养呈阳性。诊断延迟时间为1至5个月。29%的患者得以早期治疗。联合治疗使所有病例的感染均得到根除。8只眼进行了治疗营养性穿孔的结构性角膜移植术。没有患者需要进行治疗性角膜移植术来控制感染。随访结束时,9例患者的视力优于20/40,8例患者的视力为指数或更差。

结论

对于有棘阿米巴角膜炎临床表现的患者,即使培养结果为阴性,也应尽早或及时进行抗阿米巴治疗。治疗的视觉效果高度依赖于治疗的及时性。预防至关重要,应基于严格的隐形眼镜卫生习惯。

相似文献

1
[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].用丙脒腙和聚六亚甲基双胍(PHMB)治疗的棘阿米巴角膜炎
Rev Med Chil. 2002 Apr;130(4):396-401.
2
Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.用聚六亚甲基双胍和丙脒治疗棘阿米巴角膜炎的结果
Ophthalmology. 1997 Oct;104(10):1587-92. doi: 10.1016/s0161-6420(97)30092-x.
3
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.持续性培养阳性棘阿米巴角膜炎:体内耐药性与体外敏感性
Ophthalmology. 2003 Aug;110(8):1593-600. doi: 10.1016/S0161-6420(03)00481-0.
4
Acanthamoeba keratitis associated with misuse of daily disposable contact lenses.与每日抛弃型隐形眼镜滥用相关的棘阿米巴角膜炎
Cont Lens Anterior Eye. 2006 Dec;29(5):269-71. doi: 10.1016/j.clae.2006.08.002. Epub 2006 Sep 1.
5
Successful medical treatment of Acanthamoeba keratitis.棘阿米巴角膜炎的成功医学治疗。
Int Ophthalmol. 1997;21(4):223-7. doi: 10.1023/a:1006055918101.
6
Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.聚六亚甲基双胍和氯己定作为单药治疗棘阿米巴角膜炎的比较。
Am J Ophthalmol. 2008 Jan;145(1):130-5. doi: 10.1016/j.ajo.2007.08.040. Epub 2007 Nov 8.
7
Good visual outcome after prompt treatment of acanthamoeba keratitis associated with overnight orthokeratology lens wear.与过夜角膜塑形镜佩戴相关的棘阿米巴角膜炎经及时治疗后视力预后良好。
Eye Contact Lens. 2007 Nov;33(6 Pt 1):329-31. doi: 10.1097/ICL.0b013e318030d5cf.
8
Treatment of Acanthamoeba keratitis.棘阿米巴角膜炎的治疗。
Expert Rev Anti Infect Ther. 2003 Aug;1(2):205-8. doi: 10.1586/14787210.1.2.205.
9
Laser in situ keratomileusis treatment for myopia after Acanthamoeba keratitis.棘阿米巴角膜炎后近视的准分子原位角膜磨镶术治疗
Eye Contact Lens. 2004 Apr;30(2):103-4. doi: 10.1097/01.icl.00000117849.3627.b0.
10
[Acanthamoeba keratitis: about the first two Tunisian cases].[棘阿米巴角膜炎:关于突尼斯的前两例病例]
Bull Soc Pathol Exot. 2007 Feb;100(1):41-2.

引用本文的文献

1
The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage.含二硫键异构酶结构域蛋白在滋养体阶段对高耐受性棘阿米巴抵御聚六亚甲基双胍中的作用。
Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):251-257. doi: 10.1016/j.ijpddr.2016.11.001. Epub 2016 Nov 14.
2
Cationic antimicrobial polymers and their assemblies.阳离子抗菌聚合物及其组装体。
Int J Mol Sci. 2013 May 10;14(5):9906-46. doi: 10.3390/ijms14059906.
3
Polyhexamethylene biguanide functionalized cationic silver nanoparticles for enhanced antimicrobial activity.
聚六亚甲基双胍功能化的阳离子银纳米粒子,提高抗菌活性。
Nanoscale Res Lett. 2012 May 24;7(1):267. doi: 10.1186/1556-276X-7-267.
4
The resistance of the yeast Saccharomyces cerevisiae to the biocide polyhexamethylene biguanide: involvement of cell wall integrity pathway and emerging role for YAP1.酵母酿酒酵母对杀菌剂聚六亚甲基双胍的抗性:细胞壁完整性途径的参与和 Yap1 的新作用。
BMC Mol Biol. 2011 Aug 19;12:38. doi: 10.1186/1471-2199-12-38.
5
Pathogenesis of acanthamoeba keratitis.棘阿米巴角膜炎的发病机制。
Ocul Surf. 2010 Apr;8(2):70-9. doi: 10.1016/s1542-0124(12)70071-x.